Nursing care
Stimulants: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Give stimulants such as methylphenidate or amphetamine salts after breakfast, not before, to limit appetite suppression across the day. Monitor heart rate, blood pressure, weight, and in children, height and growth trajectory on a standardised chart. Hold and notify the prescriber for a resting heart rate or blood pressure outside the ordered parameters, or for new chest pain.
What it does and why it is prescribed
CNS stimulants increase dopamine and norepinephrine availability in the synaptic cleft, which improves attention, impulse control, and wakefulness. Methylphenidate and amphetamine salts are the two drug classes you will see most often, prescribed for ADHD in children and adults and for narcolepsy. Some formulations are also used short-term for treatment-resistant depression or fatigue in palliative care, though this is off-label and less common on a general ward.
Extended-release formulations dominate outpatient ADHD management because they give steady coverage through a school or work day and carry lower misuse potential than immediate-release tablets. Immediate-release forms still have a role for dose titration, for patients who need flexible afternoon dosing, or where cost limits access to the extended-release product. Knowing which formulation your patient is on matters clinically, because you cannot crush or split most extended-release capsules without disrupting the release mechanism.
Nursing considerations before giving it
Take a baseline heart rate and blood pressure before the first dose and compare against the patient's own baseline, not just a normal range, since stimulants raise both. Ask about personal or family history of sudden cardiac death, structural heart disease, or arrhythmia; these are contraindications the prescriber needs flagged before continuing. Confirm the formulation and whether it can be swallowed whole, opened onto food, or must not be crushed at all, as this varies by brand even within the same drug class.
Give the dose after breakfast rather than before it. Stimulants suppress appetite, and administering on an empty stomach compounds that effect across the day, undermining intake in patients who are already at risk of poor weight gain, particularly children. This single timing decision is one of the more testable points in stimulant nursing care and is easy to overlook if you default to giving morning medications before the meal tray arrives.
What to monitor
Track heart rate and blood pressure at intervals set by the prescriber, more frequently during initial titration. Watch for insomnia, which often means the dose is being given too late in the day rather than being an adverse effect requiring discontinuation. Screen for new or worsening tics, agitation, or mood change, since stimulants can unmask an underlying tic disorder or bipolar presentation that was not evident before treatment started.
In children, plot height and weight on a standardised growth chart at every visit, not just when a problem is suspected. Growth suppression is a known effect of long-term stimulant therapy and is only caught by trending measurements over months, not by a single reading. A flattening growth curve is the finding that prompts a drug holiday or dose review, so this monitoring point carries real clinical weight beyond routine documentation.
Side effects versus adverse effects
Expected side effects include decreased appetite, mild insomnia if dosed late, dry mouth, and a modest rise in heart rate and blood pressure that stays within the parameters set for the patient. These are managed through timing adjustments, dietary support, and reassurance rather than stopping the drug outright.
Adverse effects that cross into concerning territory include chest pain, syncope, palpitations with a heart rate well above the patient's baseline, signs of psychosis such as new hallucinations, or a growth trajectory that has dropped across two or more percentile lines. These findings change the plan of care and usually mean holding the dose and escalating, rather than documenting and continuing.
What to hold for and when to call
Hold the dose for a heart rate or blood pressure outside the parameters set by the prescriber, for new chest pain or palpitations, or for a patient reporting visual or auditory hallucinations that were not present before treatment. Hold if the patient has not eaten and you are unable to give the dose after a meal, and reschedule rather than giving it on an empty stomach if the order allows flexibility.
Call the prescriber for any cardiac symptom, for a growth chart showing a clear downward trend across visits, for emerging tics or a marked mood shift, or if a parent or adult patient describes thoughts of self-harm. These findings need a documented conversation, not just a note in the chart, because they may change the drug or the dose.
Patient teaching
Teach the patient or caregiver to take the dose after breakfast to protect appetite through the day, and to avoid giving it in the afternoon or evening unless specifically instructed, since this is the usual cause of insomnia. Explain that some appetite suppression is expected and manageable with calorie-dense breakfasts and evening snacks, but that ongoing weight loss should be reported.
For children, explain why growth is being tracked at every visit and that a temporary plateau does not automatically mean stopping treatment, but a clear downward trend will prompt a review. Tell the patient or family to report chest pain, fainting, palpitations, or any new unusual thoughts or behaviours promptly, and not to stop the medication abruptly without medical advice, since some formulations require tapering.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why do you give stimulants after breakfast instead of before?
Stimulants suppress appetite, and giving them on an empty stomach compounds that effect for the rest of the day. Giving the dose after a meal means the patient has already eaten before the appetite-suppressing effect sets in, which protects overall intake, particularly important in children on long-term therapy.
Can you crush an extended-release stimulant capsule?
It depends on the product. Some extended-release capsules, such as certain methylphenidate formulations, can be opened and the beads sprinkled on soft food without crushing the beads themselves, while others must be swallowed whole to preserve the release mechanism. Check the specific product's administration instructions rather than assuming, since this varies by brand.
What heart rate or blood pressure means you should hold a stimulant?
Hold for any reading outside the parameters set by the prescriber for that patient, and use the patient's own baseline as the reference point, not a generic normal range. Report any new chest pain, palpitations, or syncope immediately regardless of the numeric reading.
Do stimulants really stunt a child's growth?
Long-term stimulant therapy is associated with modest growth suppression in some children, which is why height and weight are plotted on a growth chart at every visit rather than checked only when a problem is suspected. A flattening curve or a drop across percentile lines is the finding that prompts a drug holiday or dose review.
Is insomnia on a stimulant a reason to stop the medication?
Not usually. Insomnia is most often a timing problem, caused by the dose being given too late in the day, and is corrected by moving the dose earlier rather than discontinuing the drug. Persistent insomnia despite correct timing should still be reported to the prescriber.
More on pharmacology
Guides on this